| |
| |
|
| Insider
Information: |
Henderson Jeffrey William |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
161,643 |
|
|
Indirect Shares
|
15 |
|
|
| Direct
Value |
$11,373,546 |
|
|
|
Indirect Value
|
$3,376 |
|
|
| Total
Shares |
161,658 |
|
|
| Total
Value |
$11,376,922 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
Chief Financial Officer |
2014-08-27 |
67,190 |
2012-09-07 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
53,611 |
2015-08-05 |
0 |
Premium* |
|
|
QUALCOMM Inc |
QCOM |
Director |
2024-03-10 |
6,408 |
|
0 |
Premium* |
|
|
Fibrogen Inc |
FGEN |
Director |
2023-09-01 |
28,866 |
2018-06-05 |
0 |
Premium* |
|
|
Becton Dickinson & Co |
BDX |
Director |
2024-01-23 |
5,568 |
2024-01-23 |
15 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
52,839 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2020-11-10 |
4 |
S |
$141.10 |
$846,602 |
D/D |
(6,000) |
1,214 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
6,405 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2024-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,501 |
53,611 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-06-08 |
4 |
AS |
$16.87 |
$122,185 |
D/D |
(7,000) |
34,866 |
0 |
% |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2006-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
28,938 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
47,110 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,289 |
41,866 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
72,107 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2010-02-01 |
4 |
D |
$33.07 |
$320,184 |
D/D |
(9,682) |
103,697 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-02-28 |
4 |
S |
$48.51 |
$485,100 |
D/D |
(10,000) |
49,045 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-03-01 |
4 |
S |
$47.71 |
$477,100 |
D/D |
(10,000) |
39,045 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,363 |
51,105 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2006-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,633 |
39,571 |
|
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2013-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,889 |
165,973 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2013-08-15 |
4 |
D |
$52.23 |
$620,910 |
D/D |
(11,888) |
171,363 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
63,278 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2007-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,247 |
50,771 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2014-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,708 |
97,172 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,135 |
40,742 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2013-07-15 |
4 |
AS |
$49.99 |
$732,853 |
D/D |
(14,660) |
131,109 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2013-07-15 |
4 |
OE |
$48.58 |
$721,559 |
D/D |
14,853 |
145,769 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2008-08-15 |
4 |
A |
$56.13 |
$839,985 |
D/D |
14,965 |
61,195 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Financial Officer |
• – – |
2014-08-15 |
4 |
D |
$72.13 |
$1,134,966 |
D/D |
(15,735) |
81,769 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,777 |
33,577 |
0 |
- |
|
113 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
